RHOA and melanoma: This is applicable to the present study, in which we found that inhibition of RhoA signaling by the RhoA‐GEF inhibitor Rhosin in WNT5A‐deficient melanoma cells resulted in an even more significant reduction in melanoma cell invasion than WNT5A knockdown alone.